Medicxi
25 Great Pulteney Street
London
W1F 9LT
United Kingdom
Tel: 44-20-7952-1788
Website: http://www.medicxi.com/
About Medicxi
medicxi (MEH-DEE-CHEE) is a life sciences-focused investment firm, originally created at Index Ventures, a leading international venture capital firm with offices in London, San Francisco, Geneva, and St. Helier (Jersey).YEAR FOUNDED:
Feb 2016
LEADERSHIP:
Founder: Francesco De Rubertis, Kevin Johnson, Michele Ollier and David Grainger
FOLLOW MEDICXI:
Tweets by Medicxi
7 articles with Medicxi
-
The new financing will help the Boston-based biotech accelerate the development of its siRNA-based therapies for immuno-dermatology indications.
-
In a stunning fall from grace playing out this week, former Operation Warp Speed vaccine czar, Dr. Moncef Slaoui, issued a statement Thursday morning, as news emerged that he has resigned from additional biotech posts.
-
Moncef Slaoui Joins Medicxi
9/19/2017
-
Diasome Pharmaceuticals Receives Funding Led By Medicxi
7/5/2017
-
Medicxi Launches First $300 Million Late-Stage Life Sciences Fund Medicxi Growth 1 (MG1), Backed By Novartis Animal Health Inc. And Verily
6/15/2017
-
Google's Verily and Novartis AG Jump Into Medicxi's $300 Million Life Science Investment Fund
6/15/2017
-
Domain Therapeutics And Medicxi Launch Mavalon Therapeutics, Aimed At Halting The Progression Of Parkinson's Disease
10/18/2016